Strides Pharma Board Meeting on Oct 29 for Q2 FY27 Results

Strides Pharma Science Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda item is the consideration and approval of the unaudited financial results, both standalone and consolidated, for the second quarter and half-year ended September 30, 2026. Additionally, the company has closed the trading window for designated persons from October 1, 2026, which will reopen 48 hours after the financial results are declared, in accordance with the company's insider trading code.